AVM0703

· AVM Biotechnology Inc

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AVM0703, covering 2025-10-02 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies [Phase 1, Phase 2]